Insights On Outsourced Drug Development
-
Unified Lab Software For Modern QC Workflows
8/17/2026
Manage increasingly complex chromatography workflows with a scalable data system that supports secure data management, instrument control, analysis, reporting, and high-resolution characterization.
-
Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids
3/31/2025
Using CRC organoids and bioprinting, explore the automation of dome assays to evaluate drug responses and delve into the insights from image-based end-point assays on the efficacy of anti-cancer treatments.
-
Context-First Data For Trustworthy AI In Biopharma
6/26/2026
Bridge the gap between AI experimentation and enterprise value. Learn how capturing structured, semantically rich data at the point of origin builds regulator-credible AI pipelines.
-
Shining A Light On Dark Data
6/11/2026
Centralizing data unlocks faster insights, reduces duplicated effort, and improves compliance. By overcoming silos and “dark data,” organizations can enable efficient search, reuse, and analysis.
-
Facts About AAV Producer Cell Lines
8/8/2025
Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.
-
Is Lipinski's Rule Of Five Still Relevant In Drug Development?
11/13/2024
Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.
-
Highly Sensitive ELISAs In 90 Minutes
9/11/2024
Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.
-
The Role Of A Consulting Firm In The IND Process
6/10/2025
Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.
-
Automated Testing For Compound Toxicity Effects
3/17/2025
Explore how anti-cancer drugs' toxic effects on intestinal cells limit dosages as well as how 3D organoids and assay automation can enhance drug development by improving testing processes.
-
Straight From The Source: A Live Q&A With The Inventors Of KinetiSolâ„¢
5/22/2026
Experts discuss a solvent-free fusion process for amorphous solid dispersions, highlighting formulation flexibility, scale-up, process control, and early strategies to reduce risk and support commercialization.